OLMA
Olema Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -8.3% ·
aandelenstroom -28.3% ·
netto nieuwe posities -9.1%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 77 | -5 | 48.00M | $600.59M | +5 | −10 |
| Q1 2026 | 85 | +7 | 50.63M | $755.34M | +15 | −8 |
| Q4 2025 | 78 | +3 | 39.80M | $995.19M | +3 | — |
| Q3 2025 | 16 | 0 | 15.07M | $147.57M | +1 | −1 |
| Q2 2025 | 13 | -1 | 13.76M | $58.63M | — | −1 |
| Q1 2025 | 11 | -1 | 8.23M | $30.93M | +1 | −2 |
| Q4 2024 | 12 | 0 | 11.47M | $66.81M | — | — |
| Q3 2024 | 11 | 0 | 7.78M | $92.93M | +1 | −1 |
| Q2 2024 | 11 | — | 6.52M | $70.59M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 1.87M | +11.2% | $7.04M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 1.47M | -3.4% | $5.54M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 1.47M | -3.4% | $5.54M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.47M | -3.4% | $5.54M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.47M | -3.4% | $5.54M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.47M | -3.4% | $5.54M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 1.44M | -60.7% | $5.42M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passief) | 1.08M | +16.9% | $4.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passief) | 1.08M | +16.9% | $4.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 978.85K | 0.0% | $3.68M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | State Street Global Advisors ✦ (passief) | 865.56K | -53.4% | $3.25M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Marshall Wace ✦ | 319.95K | +65.8% | $1.20M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Marshall Wace ✦ | 319.95K | +65.8% | $1.20M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 64.60K | -58.9% | $242,896 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 62.93K | -13.7% | $236,602 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 45.66K | Nieuw | $171,686 | 0.0% | New | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 45.66K | Nieuw | $171,686 | 0.0% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 45.66K | Nieuw | $171,686 | 0.0% | New | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 45.66K | Nieuw | $171,686 | 0.0% | New | 1 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 17.54K | -32.8% | $66,000 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| AQR Capital Management | $171,686 | 0.0% |
| AQR Capital Management | $171,686 | 0.0% |
| AQR Capital Management | $171,686 | 0.0% |
| AQR Capital Management | $171,686 | 0.0% |
Verlaten
| Adage Capital Partners | $2.13M | was 0.0% |
| D. E. Shaw & Co. | $72,554 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 200.00K aandelen, $10,000 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.